top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Adverse effects of pertussis and rubella vaccines [[electronic resource] ] : a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines / / Christopher P. Howson, Cynthia J. Howe, and Harvey V. Fineberg, editors
Adverse effects of pertussis and rubella vaccines [[electronic resource] ] : a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines / / Christopher P. Howson, Cynthia J. Howe, and Harvey V. Fineberg, editors
Pubbl/distr/stampa Washington, D.C., : National Academy Press, 1991
Descrizione fisica 1 online resource (xii, 367 pages) : illustrations
Disciplina 615/.372
Altri autori (Persone) HowsonChristopher Paul
HoweCynthia J
FinebergHarvey V
Soggetto topico Pertussis vaccines - Side effects
Rubella vaccines - Side effects
Whooping cough - Vaccination - Complications
Rubella - Vaccination - Complications
Soggetto genere / forma Electronic books.
ISBN 1-280-20370-6
9786610203703
0-309-55597-3
0-585-03433-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910456250803321
Washington, D.C., : National Academy Press, 1991
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Adverse effects of pertussis and rubella vaccines : a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines / / editors, Christopher P. Howson, Cynthia J. Howe, Harvey V. Fineberg
Adverse effects of pertussis and rubella vaccines : a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines / / editors, Christopher P. Howson, Cynthia J. Howe, Harvey V. Fineberg
Pubbl/distr/stampa Washington, D.C. : , : National Academy Press, , 1991
Descrizione fisica 1 online resource (xii, 367 pages) : illustrations
Disciplina 615/.372
Altri autori (Persone) HowsonChristopher Paul
HoweCynthia J
FinebergHarvey V
Soggetto topico Pertussis vaccines - Side effects
Rubella vaccines - Side effects
Whooping cough - Vaccination - Complications
Rubella - Vaccination - Complications
ISBN 1-280-20370-6
9786610203703
0-309-55597-3
0-585-03433-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910778503103321
Washington, D.C. : , : National Academy Press, , 1991
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Adverse effects of pertussis and rubella vaccines : a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines / / Christopher P. Howson, Cynthia J. Howe, and Harvey V. Fineberg, editors
Adverse effects of pertussis and rubella vaccines : a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines / / Christopher P. Howson, Cynthia J. Howe, and Harvey V. Fineberg, editors
Edizione [1st ed.]
Pubbl/distr/stampa Washington, D.C., : National Academy Press, 1991
Descrizione fisica 1 online resource (xii, 367 pages) : illustrations
Disciplina 615/.372
Altri autori (Persone) HowsonChristopher Paul
HoweCynthia J
FinebergHarvey V
Soggetto topico Pertussis vaccines - Side effects
Rubella vaccines - Side effects
Whooping cough - Vaccination - Complications
Rubella - Vaccination - Complications
Pertussis Vaccine - adverse effects
Rubella Vaccine - adverse effects
Soggetto genere / forma Congress
ISBN 9786610203703
9781280203701
1280203706
9780309555975
0309555973
9780585034331
0585034338
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Adverse Effects of Pertussis and Rubella Vaccines -- Copyright -- Preface -- Acknowledgments -- Contents -- Adverse Effects of PERTUSSIS and RUBELLA Vaccines -- 1 Executive Summary -- METHODOLOGIC CONSIDERATIONS IN EVALUATING THE EVIDENCE -- SUMMARY AND CONCLUSIONS -- RESEARCH NEEDS -- 2 Histories of Pertussis and Rubella Vaccines -- PERTUSSIS VACCINES -- Epidemiology of Whooping Cough -- Clinical Description -- Diagnosis -- Complications -- Descriptive Epidemiology -- Nature of the Causative Organism, B. pertussis -- Major Milestones in the Development of Pertussis Vaccines -- Whole-Cell Vaccines -- Acellular Vaccines -- Brief History of the Controversy Pertaining to Adverse Events Following Pertussis Vaccination -- RUBELLA VACCINES -- Epidemiology of the Disease Rubella -- Clinical Description -- Diagnosis -- Complications -- Descriptive Epidemiology -- Nature of the Rubella Virus -- Major Milestones in the Development of Rubella Vaccines -- Brief History of the Controversy Pertaining to Adverse Events Following Rubella Vaccination -- REFERENCES -- 3 Methodologic Considerations in Evaluating the Evidence -- THE NATURE OF THE EVIDENCE -- QUESTIONS TO BE ADDRESSED -- (1) Can vaccine cause the adverse event? -- (2) How frequently does vaccine cause the event? -- (3) Did vaccination cause a particular case of the adverse event? -- THE BURDEN OF PROOF -- CATEGORIES OF EVIDENCE -- Experiments in Humans -- Randomized Controlled Trials -- Other Experimental Studies -- Experiments in Animals: Animal Models -- Controlled Epidemiologic Studies (Observational) -- Cohort Studies -- Case-Comparison Studies -- Other Controlled Studies -- Case Reports and Case Series -- Searching for Patterns -- Historical Comparisons -- Causation of the Individual Case -- Monitoring System for Adverse Events Following Immunization -- ASSESSMENT OF THE EVIDENCE.
Evaluation of Single Studies -- Integration of the Collective Results -- Meta-Analysis -- Considerations in Inferring Causality -- THE NATURE OF THE CONCLUSIONS -- Quantitation -- Resolution -- Uncertainty and Confidence -- Quality -- Comprehensiveness -- Neutrality -- Judgment -- SUMMARY OF THE EVIDENCE -- REFERENCES -- 4 Evidence Concerning Pertussis Vaccines and Central Nervous System Disorders, Including Infantile... -- INFANTILE SPASMS -- Clinical Description -- Descriptive Epidemiology -- History of Suspected Association with Pertussis Vaccines -- Evidence from Studies in Humans -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- Summary -- Conclusion -- HYPSARRHYTHMIA -- Clinical Description -- Descriptive Epidemiology -- History of Suspected Association with Pertussis Vaccines -- Evidence from Studies in Humans -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- Summary -- Conclusion -- ASEPTIC MENINGITIS -- Clinical Description -- Descriptive Epidemiology -- History of Suspected Association with Pertussis Vaccines -- Evidence from Studies in Humans -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- Summary -- Conclusion -- ENCEPHALOPATHY -- Clinical Description -- Encephalopathy Following Whooping Cough -- Pathology -- Descriptive Epidemiology -- History of Suspected Association with Pertussis Vaccines -- Evidence from Studies in Humans -- Case Reports and Case Series -- Studies in Defined Populations -- The National Childhood Encephalopathy Study -- Other Controlled Studies in Humans -- Evidence from Studies in Animals -- Aluminum Salts -- Summary -- Conclusion -- REFERENCES -- 5 Evidence Concerning Pertussis Vaccines and Deaths Classified as Sudden Infant Death Syndrome -- CLINICAL DESCRIPTION, DIAGNOSIS, AND PATHOLOGY -- DESCRIPTIVE EPIDEMIOLOGY.
HISTORY OF SUSPECTED ASSOCIATION WITH PERTUSSIS VACCINES -- EVIDENCE FROM STUDIES IN HUMANS -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- SUMMARY -- CONCLUSION -- REFERENCES -- 6 Evidence Concerning Pertussis Vaccines and Other Illnesses and Conditions -- ANAPHYLAXIS -- Clinical Description and Pathologic Aspects -- History of Suspected Association with Pertussis Vaccines -- Evidence from Studies in Humans -- Case Reports and Controlled Epidemiologic Studies -- Evidence from Studies in Animals -- Endotoxin -- Summary -- Conclusion -- AUTISM -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Summary -- Conclusion -- ERYTHEMA MULTIFORME OR OTHER RASH -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Aluminum Salts -- Summary -- Conclusion -- GUILLAIN-BARRÉ SYNDROME (POLYNEUROPATHY) -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Summary -- Conclusion -- PERIPHERAL MONONEUROPATHY -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Summary -- Conclusion -- HEMOLYTIC ANEMIA -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Summary -- Conclusion -- JUVENILE DIABETES -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Controlled Epidemiologic Study -- Case Report -- Evidence from Studies in Animals -- Summary -- Conclusion -- LEARNING DISABILITIES AND HYPERACTIVITY -- Clinical Description -- Learning Disability, Reading Disability, and Dyslexia -- Hyperactivity, Hyperkinesis, and Attention Deficit Disorder -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Controlled Epidemiologic Studies -- Summary.
Conclusion -- PROTRACTED INCONSOLABLE CRYING AND SCREAMING -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- Summary -- Conclusions -- REYE SYNDROME -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Controlled Epidemiologic Study -- Case Reports and Case Series -- Summary -- Conclusion -- SHOCK AND ''UNUSUAL SHOCK-LIKE STATE" WITH HYPOTONICITY, HYPORESPONSIVENESS, AND SHORT-LIVED CONVULS ... -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- Summary -- Conclusion -- THROMBOCYTOPENIA -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports and Case Series -- Summary -- Conclusion -- REFERENCES -- 7 Evidence Concerning Rubella Vaccines and Arthritis, Radiculoneuritis, and Thrombocytopenic Purpura -- ARTHRITIS -- Clinical Description and Pathologic Aspects -- Descriptive Epidemiology -- History of an Association with Rubella Vaccines -- Evidence from Studies in Humans -- Acute Arthropathy and Arthritis -- Chronic Arthritis -- Evidence from Studies in Animals -- Possible Mechanisms -- Summary -- Acute Arthropathy and Arthritis -- Chronic Arthritis -- Conclusions -- RADICULONEURITIS AND OTHER NEUROPATHIES -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports and Case Series -- Summary -- Conclusion -- THROMBOCYTOPENIC PURPURA -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Summary -- Conclusion -- REFERENCES -- Afterword on Research Needs -- Bibliography -- Glossary of Terms B -- Appendixes.
A Strategies For Gathering Information: Adverse Effects of Pertussis and Rubella Vaccines -- LITERATURE SEARCHES -- Electronic Data Bases -- OTHER SOURCES -- Reference Lists -- Presentations -- Public Meeting (January 10, 1990) -- Workshop (May 14, 1990) -- Committee Meeting (May 15, 1990) -- Additional Individuals and Organizations Who Provided Information -- Review of Interim Bibliography -- ABSTRACTION OF DATA FROM CASE REPORTS, CASE SERIES, AND CONTROLLED STUDIES -- Rationale -- Procedures for Abstraction and Adjudication of Study Data -- B Pertussis and Rubella Vaccines: A Brief Chronology -- PERTUSSIS VACCINES -- RUBELLA VACCINES -- REFERENCES -- C Animal Models for the Study of Whooping Cough and the Testing of Vaccine Materials -- ANIMAL MODELS FOR THE STUDY OF WHOOPING COUGH -- STANDARDIZED ANIMAL TESTS OF VACCINE MATERIALS -- REFERENCES -- D Technical Details of Power Calculations and Meta-Analyses -- POWER CALCULATIONS -- META-ANALYSES -- Formal Analysis -- Informal Analysis -- REFERENCES -- E Possible Involvement of Aluminum Salts in Erythema Multiforme, Encephalopathy, or Other Adverse E ... -- REFERENCES -- F Committee and Staff Biographies -- COMMITTEE -- STAFF -- Index.
Record Nr. UNINA-9910965570303321
Washington, D.C., : National Academy Press, 1991
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Society's choices [[electronic resource] ] : social and ethical decision making in biomedicine / / Ruth Ellen Bulger, Elizabeth Meyer Bobby, and Harvey V. Fineberg, editors ; Committee on the Social and Ethical Impacts of Developments in Biomedicine, Division of Health Sciences Policy, Institute of Medicine
Society's choices [[electronic resource] ] : social and ethical decision making in biomedicine / / Ruth Ellen Bulger, Elizabeth Meyer Bobby, and Harvey V. Fineberg, editors ; Committee on the Social and Ethical Impacts of Developments in Biomedicine, Division of Health Sciences Policy, Institute of Medicine
Pubbl/distr/stampa Washington, D.C., : National Academy Press, 1995
Descrizione fisica 1 online resource (560 p.)
Disciplina 174/.2
Altri autori (Persone) BulgerRuth Ellen
BobbyElizabeth Meyer
FinebergHarvey V
Soggetto topico Medical ethics
Bioethics
Soggetto genere / forma Electronic books.
ISBN 0-309-59853-2
0-585-02000-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto ""SOCIETY'S CHOICES""; ""Copyright""; ""Preface""; ""Acknowledgments""; ""Contents""; ""Executive Summary""; ""SOURCES OF ETHICAL ISSUES IN BIOMEDICINE""; ""THE SOCIETAL CONTEXT OF BIOETHICAL PROBLEM SOLVING""; ""SYSTEMATIC APPROACHES TO BIOETHICS""; ""THE SPECTRUM OF SOCIETAL RESPONSES""; ""Political and Legal Mechanisms""; ""Professional and Institutional Mechanisms""; ""Individual and Community Responses""; ""CRITERIA FOR SUCCESS""; ""Intellectual Integrity: Logic, Scholarship, and Sound Judgment""; ""Logic""; ""Scholarship""; ""Sound Judgment""
""Sensitivity to Democratic Values: Respect, Representation, and Openness""""Respect for Affected Parties""; ""Representation of Diverse Views""; ""Open versus Closed Meetings""; ""Effectiveness: Communication, Authority""; ""Communication""; ""Authority""; ""Different Goals, Different Yardsticks of Success: Achieving Consensus, Achieving Results""; ""Can Bioethics Be Disadvantageous?""; ""CONCLUSIONS AND RECOMMENDATIONS""; ""A Multilevel Approach to Bioethics Deliberation""; ""Nongovernmental Organizations and Individuals""; ""States""; ""Advisory Bodies in Federal Agencies""
""A Supra-agency Commission""""PART I""; "" 1 Introduction""; ""DEFINING ""ETHICAL"" ISSUES""; ""SOURCES OF ETHICAL ISSUES IN BIOMEDICINE""; ""Biomedical Research Involving Human Subjects""; ""Changes in Health Care""; ""Making Decisions About Health Care""; ""The Health Care System: Financing and Structure""; ""New Diagnostic and Therapeutic Capabilities in Medicine""; ""Academic-Industry Relationships in Biotechnology""; ""REFERENCES""; "" 2 The Social Context of Bioethical""; ""THE AMERICAN CHARACTER""; ""Ambivalence About Government""; ""The Political Process""; ""The Religious Sphere""
""ACTORS SHAPING THE SOCIAL CONTEXT FOR BIOETHICS""""Minorities: A History of Distrust""; ""Women: A Struggle for Control""; ""Gays and Lesbians: A New Activism""; ""HEALTH CARE AND SCIENCE: SHAPING THE SOCIAL CONTEXT FOR BIOETHICS""; ""Patients, Employers, and Insurance Companies: Health Care Consumers""; ""Hospitals""; ""The Health Care Industry""; ""Biomedical Research: The Federal Government and Private Industry""; ""Funding of Scientific Research""; ""REFERENCES""; "" 3 Systematic Approaches To Bioethics""; ""ACADEMIC BIOETHICS""; ""Definitions""; ""Origins""; ""Contributions""
""Contributions of Religious Ethicists to Biomedical Questions""""Dangerous Ways to Present Religious Ethics""; ""Hopeful Developments""; ""SCIENTISTS AND OTHER TECHNICAL EXPERTS""; ""Science as a Discursive Model""; ""Scientists' Ethical Intuition""; ""Facts and Values""; ""Outlook""; ""HEALTH CARE PROFESSIONAL EDUCATION""; ""Origins""; ""Contributions""; ""REFERENCES""; "" 4 The Spectrum of Societal Responses""; ""POLITICAL AND LEGAL MECHANISMS""; ""Commissions Established by Congress""; ""National Commission""; ""President's Commission""; ""Biomedical Ethics Board""
""Ethics Bodies in the Executive Branch""
Record Nr. UNINA-9910456015703321
Washington, D.C., : National Academy Press, 1995
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Society's choices [[electronic resource] ] : social and ethical decision making in biomedicine / / Ruth Ellen Bulger, Elizabeth Meyer Bobby, and Harvey V. Fineberg, editors ; Committee on the Social and Ethical Impacts of Developments in Biomedicine, Division of Health Sciences Policy, Institute of Medicine
Society's choices [[electronic resource] ] : social and ethical decision making in biomedicine / / Ruth Ellen Bulger, Elizabeth Meyer Bobby, and Harvey V. Fineberg, editors ; Committee on the Social and Ethical Impacts of Developments in Biomedicine, Division of Health Sciences Policy, Institute of Medicine
Pubbl/distr/stampa Washington, D.C., : National Academy Press, 1995
Descrizione fisica 1 online resource (560 p.)
Disciplina 174/.2
Altri autori (Persone) BulgerRuth Ellen
BobbyElizabeth Meyer
FinebergHarvey V
Soggetto topico Medical ethics
Bioethics
ISBN 0-309-17676-X
0-309-59853-2
0-585-02000-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto ""SOCIETY'S CHOICES""; ""Copyright""; ""Preface""; ""Acknowledgments""; ""Contents""; ""Executive Summary""; ""SOURCES OF ETHICAL ISSUES IN BIOMEDICINE""; ""THE SOCIETAL CONTEXT OF BIOETHICAL PROBLEM SOLVING""; ""SYSTEMATIC APPROACHES TO BIOETHICS""; ""THE SPECTRUM OF SOCIETAL RESPONSES""; ""Political and Legal Mechanisms""; ""Professional and Institutional Mechanisms""; ""Individual and Community Responses""; ""CRITERIA FOR SUCCESS""; ""Intellectual Integrity: Logic, Scholarship, and Sound Judgment""; ""Logic""; ""Scholarship""; ""Sound Judgment""
""Sensitivity to Democratic Values: Respect, Representation, and Openness""""Respect for Affected Parties""; ""Representation of Diverse Views""; ""Open versus Closed Meetings""; ""Effectiveness: Communication, Authority""; ""Communication""; ""Authority""; ""Different Goals, Different Yardsticks of Success: Achieving Consensus, Achieving Results""; ""Can Bioethics Be Disadvantageous?""; ""CONCLUSIONS AND RECOMMENDATIONS""; ""A Multilevel Approach to Bioethics Deliberation""; ""Nongovernmental Organizations and Individuals""; ""States""; ""Advisory Bodies in Federal Agencies""
""A Supra-agency Commission""""PART I""; "" 1 Introduction""; ""DEFINING ""ETHICAL"" ISSUES""; ""SOURCES OF ETHICAL ISSUES IN BIOMEDICINE""; ""Biomedical Research Involving Human Subjects""; ""Changes in Health Care""; ""Making Decisions About Health Care""; ""The Health Care System: Financing and Structure""; ""New Diagnostic and Therapeutic Capabilities in Medicine""; ""Academic-Industry Relationships in Biotechnology""; ""REFERENCES""; "" 2 The Social Context of Bioethical""; ""THE AMERICAN CHARACTER""; ""Ambivalence About Government""; ""The Political Process""; ""The Religious Sphere""
""ACTORS SHAPING THE SOCIAL CONTEXT FOR BIOETHICS""""Minorities: A History of Distrust""; ""Women: A Struggle for Control""; ""Gays and Lesbians: A New Activism""; ""HEALTH CARE AND SCIENCE: SHAPING THE SOCIAL CONTEXT FOR BIOETHICS""; ""Patients, Employers, and Insurance Companies: Health Care Consumers""; ""Hospitals""; ""The Health Care Industry""; ""Biomedical Research: The Federal Government and Private Industry""; ""Funding of Scientific Research""; ""REFERENCES""; "" 3 Systematic Approaches To Bioethics""; ""ACADEMIC BIOETHICS""; ""Definitions""; ""Origins""; ""Contributions""
""Contributions of Religious Ethicists to Biomedical Questions""""Dangerous Ways to Present Religious Ethics""; ""Hopeful Developments""; ""SCIENTISTS AND OTHER TECHNICAL EXPERTS""; ""Science as a Discursive Model""; ""Scientists' Ethical Intuition""; ""Facts and Values""; ""Outlook""; ""HEALTH CARE PROFESSIONAL EDUCATION""; ""Origins""; ""Contributions""; ""REFERENCES""; "" 4 The Spectrum of Societal Responses""; ""POLITICAL AND LEGAL MECHANISMS""; ""Commissions Established by Congress""; ""National Commission""; ""President's Commission""; ""Biomedical Ethics Board""
""Ethics Bodies in the Executive Branch""
Record Nr. UNINA-9910778763703321
Washington, D.C., : National Academy Press, 1995
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Society's choices : social and ethical decision making in biomedicine / / Ruth Ellen Bulger, Elizabeth Meyer Bobby, and Harvey V. Fineberg, editors ; Committee on the Social and Ethical Impacts of Developments in Biomedicine, Division of Health Sciences Policy, Institute of Medicine
Society's choices : social and ethical decision making in biomedicine / / Ruth Ellen Bulger, Elizabeth Meyer Bobby, and Harvey V. Fineberg, editors ; Committee on the Social and Ethical Impacts of Developments in Biomedicine, Division of Health Sciences Policy, Institute of Medicine
Edizione [1st ed.]
Pubbl/distr/stampa Washington, D.C., : National Academy Press, 1995
Descrizione fisica 1 online resource (560 p.)
Disciplina 174/.2
Altri autori (Persone) BulgerRuth Ellen
BobbyElizabeth Meyer
FinebergHarvey V
Soggetto topico Medical ethics
Bioethics
ISBN 9780309176767
030917676X
9780309598538
0309598532
9780585020006
0585020000
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto ""SOCIETY'S CHOICES""; ""Copyright""; ""Preface""; ""Acknowledgments""; ""Contents""; ""Executive Summary""; ""SOURCES OF ETHICAL ISSUES IN BIOMEDICINE""; ""THE SOCIETAL CONTEXT OF BIOETHICAL PROBLEM SOLVING""; ""SYSTEMATIC APPROACHES TO BIOETHICS""; ""THE SPECTRUM OF SOCIETAL RESPONSES""; ""Political and Legal Mechanisms""; ""Professional and Institutional Mechanisms""; ""Individual and Community Responses""; ""CRITERIA FOR SUCCESS""; ""Intellectual Integrity: Logic, Scholarship, and Sound Judgment""; ""Logic""; ""Scholarship""; ""Sound Judgment""
""Sensitivity to Democratic Values: Respect, Representation, and Openness""""Respect for Affected Parties""; ""Representation of Diverse Views""; ""Open versus Closed Meetings""; ""Effectiveness: Communication, Authority""; ""Communication""; ""Authority""; ""Different Goals, Different Yardsticks of Success: Achieving Consensus, Achieving Results""; ""Can Bioethics Be Disadvantageous?""; ""CONCLUSIONS AND RECOMMENDATIONS""; ""A Multilevel Approach to Bioethics Deliberation""; ""Nongovernmental Organizations and Individuals""; ""States""; ""Advisory Bodies in Federal Agencies""
""A Supra-agency Commission""""PART I""; "" 1 Introduction""; ""DEFINING ""ETHICAL"" ISSUES""; ""SOURCES OF ETHICAL ISSUES IN BIOMEDICINE""; ""Biomedical Research Involving Human Subjects""; ""Changes in Health Care""; ""Making Decisions About Health Care""; ""The Health Care System: Financing and Structure""; ""New Diagnostic and Therapeutic Capabilities in Medicine""; ""Academic-Industry Relationships in Biotechnology""; ""REFERENCES""; "" 2 The Social Context of Bioethical""; ""THE AMERICAN CHARACTER""; ""Ambivalence About Government""; ""The Political Process""; ""The Religious Sphere""
""ACTORS SHAPING THE SOCIAL CONTEXT FOR BIOETHICS""""Minorities: A History of Distrust""; ""Women: A Struggle for Control""; ""Gays and Lesbians: A New Activism""; ""HEALTH CARE AND SCIENCE: SHAPING THE SOCIAL CONTEXT FOR BIOETHICS""; ""Patients, Employers, and Insurance Companies: Health Care Consumers""; ""Hospitals""; ""The Health Care Industry""; ""Biomedical Research: The Federal Government and Private Industry""; ""Funding of Scientific Research""; ""REFERENCES""; "" 3 Systematic Approaches To Bioethics""; ""ACADEMIC BIOETHICS""; ""Definitions""; ""Origins""; ""Contributions""
""Contributions of Religious Ethicists to Biomedical Questions""""Dangerous Ways to Present Religious Ethics""; ""Hopeful Developments""; ""SCIENTISTS AND OTHER TECHNICAL EXPERTS""; ""Science as a Discursive Model""; ""Scientists' Ethical Intuition""; ""Facts and Values""; ""Outlook""; ""HEALTH CARE PROFESSIONAL EDUCATION""; ""Origins""; ""Contributions""; ""REFERENCES""; "" 4 The Spectrum of Societal Responses""; ""POLITICAL AND LEGAL MECHANISMS""; ""Commissions Established by Congress""; ""National Commission""; ""President's Commission""; ""Biomedical Ethics Board""
""Ethics Bodies in the Executive Branch""
Altri titoli varianti Social and ethical decision making in biomedicine
Record Nr. UNINA-9910969846003321
Washington, D.C., : National Academy Press, 1995
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Understanding risk [[electronic resource] ] : informing decisions in a democratic society / / Paul C. Stern and Harvey V. Fineberg, editors
Understanding risk [[electronic resource] ] : informing decisions in a democratic society / / Paul C. Stern and Harvey V. Fineberg, editors
Pubbl/distr/stampa Washington, D.C., : National Academy Press, 1996
Descrizione fisica xii, 249 p
Disciplina 302/.12
Altri autori (Persone) SternPaul C. <1944->
FinebergHarvey V
Soggetto topico Risk assessment
Policy sciences
Soggetto genere / forma Electronic books.
ISBN 1-280-21082-6
9786610210824
0-309-57849-3
0-585-00242-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910455385903321
Washington, D.C., : National Academy Press, 1996
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Understanding risk : informing decisions in a democratic society / / Paul C. Stern and Harvey V. Fineberg, editors
Understanding risk : informing decisions in a democratic society / / Paul C. Stern and Harvey V. Fineberg, editors
Pubbl/distr/stampa Washington, D.C. : , : National Academy Press, , 1996
Descrizione fisica 1 online resource (xii, 249 pages)
Disciplina 302/.12
Altri autori (Persone) SternPaul C. <1944->
FinebergHarvey V
Soggetto topico Risk assessment
Policy sciences
ISBN 0-309-13324-6
1-280-21082-6
9786610210824
0-309-57849-3
0-585-00242-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910778622703321
Washington, D.C. : , : National Academy Press, , 1996
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Understanding risk : informing decisions in a democratic society / / Paul C. Stern and Harvey V. Fineberg, editors
Understanding risk : informing decisions in a democratic society / / Paul C. Stern and Harvey V. Fineberg, editors
Edizione [1st ed.]
Pubbl/distr/stampa Washington, D.C., : National Academy Press, 1996
Descrizione fisica 1 online resource (xii, 249 pages)
Disciplina 302/.12
Altri autori (Persone) SternPaul C. <1944->
FinebergHarvey V
Soggetto topico Risk assessment
Policy sciences
ISBN 9786610210824
9780309133241
0309133246
9781280210822
1280210826
9780309578493
0309578493
9780585002422
0585002428
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Understanding Risk -- Copyright -- Acknowledgments -- Contents -- Preface -- Summary -- 1 The Idea of Risk Characterization -- BEYOND TRANSLATION -- A Decision-Driven Activity -- Recognizing All Significant Concerns -- An Analytic-Deliberative Process -- Matching the Process to the Decision -- PARTICIPATION AND KNOWLEDGE IN RISK DECISIONS -- Rationales for Participation -- Role of Science -- AN EXPANDED FRAMEWORK -- A New Definition and Its Implications -- The Risk Assessment-Risk Management Distinction -- Structure of the Book -- 2 Judgment in the Risk Decision Process -- PROBLEM FORMULATION -- The Concept of Risk -- Missing Considerations -- Fairness -- Prevention -- Rights -- SELECTION OF OPTIONS AND OUTCOMES -- Ecological Effects -- Economic and Social Effects -- Effects on Future Generations -- Ripple Effects -- Effects on Democracy, Governance, and Ethical Beliefs -- Conclusion -- INFORMATION GATHERING AND INTERPRETATION -- Choosing a Risk Measure -- Making Simplifying Assumptions -- SYNTHESIS -- Summarization -- The Multidimensional Nature of Risk -- The Meaning of Risk Estimates -- Uncertainty -- Specific Populations -- Multiple Exposures -- Communication -- CONCLUSION: THE IMPORTANCE OF PROCESS DESIGN -- 3 Deliberation -- ROLE OF DELIBERATION -- PURPOSES OF BROADLY BASED DELIBERATION -- LIMITATIONS AND CHALLENGES -- Limitations -- Challenges -- STANDARDS AND GOALS FOR DELIBERATION -- Involve the Interested and Affected Parties -- Who Are the Interested and Affected Parties? -- Is Direct Participation Needed? -- Selecting Participants -- Timing Participation -- Listening to the Participants -- Explicitly Address External Constraints -- Strive for Fairness in the Process -- Plan for Flexibility and Iteration -- Recognize the Roles of the Responsible Organization -- Use Appropriate Methods -- 4 Analysis.
PURPOSES AND CHALLENGES OF ANALYSIS -- STANDARDS FOR GOOD ANALYSIS -- ANALYSIS TO REDUCE THE COMPLEXITY OF RISK -- THE ANALYSIS OF UNCERTAINTY -- Uncertainties that Matter -- Purposes -- Limits -- Social Context -- Summary and Implications -- CONCLUSIONS -- 5 Integrating Analysis and Deliberation -- PROBLEM FORMULATION -- PROCESS DESIGN -- SELECTION OF OPTIONS AND OUTCOMES -- INFORMATION GATHERING AND INTERPETATION -- SYNTHESIS OF INFORMATION -- ACHIEVING CLOSURE -- CONCLUSION -- 6 Implementing the New Approach -- PRACTICALITY -- DIAGNOSIS: MATCHING THE PROCESS TO THE DECISION -- The Risk Decision Landscape -- Unique and Wide-Impact Decisions -- Routine and Narrow-Impact Decisions -- Repeated, Wide-Impact Decisions -- Generic Hazard and Dose-Response Characterizations -- Decisions about Policies for Risk Analysis -- Diagnostic Steps and Questions -- 1. Diagnose the Kind of Risk and the State of Knowledge -- 2. Describe the Legal Mandate -- 3. Describe the Purpose of the Risk Decision -- 4. Describe the Affected Parties and Likely Public Reactions -- 5. Estimate Resource Needs and Timetable -- 6. Plan for Organizational Needs -- 7. Develop a Preliminary Process Design -- 8. Summarize and Discuss Diagnosis within the Organization -- Conclusion -- BUILDING ORGANIZATIONAL CAPABILITY -- Organizational Issues -- Improving the Knowledge Base -- CONCLUSION -- 7 Principles for Risk Characterization -- Appendix A Six Cases in Risk Analysis and Characterization -- APPLICATION OF ECOSYSTEM MANAGEMENT PRINCIPLES FOR THE SUSTAINABILITY OF SOUTH FLORIDA -- APPLICATION TO SOUTH FLORIDA -- Implications of the Case Study -- APPROVAL OF THE WASTE TECHNOLOGIES, INC. INCINERATOR AT EAST LIVERPOOL, OHIO -- REGULATORY NEGOTIATION FOR A DISINFECTANT BY-PRODUCTS RULE -- Forming the Negotiating Committee and Technical Support -- Defining the Problem and Informational Needs.
Integrating Deliberation and Analysis -- A Creative Solution to Handling Uncertainty -- Conclusions -- SITING A POWER PLANT WITH THE AID OF DECISION ANALYSIS TOOLS -- Multiattribute Utility Analysis -- The Decision Process -- Additional Features of the Case -- THE CALIFORNIA COMPARATIVE RISK PROJECT -- PLANNING FUTURE LAND USES AT HANFORD, WASHINGTON -- Appendix B Common Approaches to Deliberation and Public Participation -- PUBLIC HEARINGS -- CITIZEN ADVISORY COMMITTEES AND TASK FORCES -- ALTERNATIVE DISPUTE RESOLUTION -- CITIZENS' JURIES AND CITIZENS' PANELS -- SURVEYS -- FOCUS GROUPS -- INTERACTIVE TECHNOLOGY-BASED APPROACHES -- COMBINATIONS OF DELIBERATIVE METHODS -- Appendix C Biographical Sketches -- Glossary -- References -- Index.
Record Nr. UNINA-9910957221403321
Washington, D.C., : National Academy Press, 1996
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui